智通财经APP讯，微创机器人-B(02252)发布截至2025年6月30日止6个月中期业绩，该集团取得收入1.76亿元，同比增加77%;期内经调整净亏损9710.8万元，同比减少55.5%;公司权益股东应占亏损 1.13亿元，同比减少59.1%;每股亏损0.11元。
公告称，收入增长主要得益于多个产品商业化的快速拓展，特别是海外市场的收入实现了同比189%的大幅增长。
公司核心产品图迈腔镜手术机器人(图迈)继续保持强劲的增长势头，特别是海外市场成为收入增长的核心引擎;鸿鹄骨科手术机器人于国内外市场充分利用微创医疗集团的成熟销售网络，实现核心区域的快速覆盖与渗透，同时自主布局新兴区域，打造“双轮驱动”模式，实现稳步增长;血管介入手术机器人R-ONE上市后，获得市场的认可，需求稳步上升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.